Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8765167 | MITSUBISHI HOLDINGS | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb, 2024
(a month ago) | |
US8603514 | MITSUBISHI HOLDINGS | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr, 2024
(4 days from now) |
Market Authorisation Date: 22 November, 2019
Treatment: NA
Dosage: FILM;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8765150 | ITALFARMACO SPA | Riluzole aqueous suspensions |
Mar, 2029
(4 years from now) |
Market Authorisation Date: 05 September, 2018
Treatment: A method of treating amyotrophic lateral sclerosis in a patient in need of such treatment, said method comprising administering to said patient an effective amount of a suspension according to claim 1
Dosage: SUSPENSION;ORAL